Who
Erez Kalir
Director
Company insider
Files Form 4 as: Director, Vor Biopharma; 10% owner, Filana Therapeutics.
In numbers
- Trades disclosed
- 7
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $1.8M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 3 Oct 2011
- Last trade
- 11 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 12 Jun 2026 | VOR Vor Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —57,162 at $0.00 | filing |
| 11 Jun 2026filed 12 Jun 2026 | VOR Vor Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —57,162 at $0.00 | filing |
| 22 May 2025filed 23 May 2025 | VOR Vor Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 6 Jan 2025filed 8 Jan 2025 | VOR Vor Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 4 Oct 2011filed 5 Oct 2011 | FLNA Filana TherapeuticsBiotechnology | SEC FORM 4 Sold | $1.2M265,000 at $4.50 | filing |
| 4 Oct 2011filed 5 Oct 2011 | FLNA Filana TherapeuticsBiotechnology | SEC FORM 4 Sold | $238K50,000 at $4.75 | filing |
| 3 Oct 2011filed 5 Oct 2011 | FLNA Filana TherapeuticsBiotechnology | SEC FORM 4 Sold | $324K67,000 at $4.83 | filing |
News
No headline names them, or the companies they trade most, lately.